Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 6261-6270 of 13615

Page
per page
  1. Cyclobenzaprine HCl
    B5994 Cyclobenzaprine HCl
    Summary: 5-HT2 receptor antagonist
      ≥15.59 mg/mL
  2. A 779
    B6056 A 779
     2 Citation
    Summary: angiotensin-(1-7)/ Mas receptor antagonist
      ≥29.1 mg/mL
  3. L-Thyroxine
    B2107 L-Thyroxine
    Summary: Iodine containing hormone
      ≥27.35 mg/mL
  4. Fluconazole
    B2094 Fluconazole
     6 Citation
    Target: Cytochrome P450 (CYP450)
    Summary: fungal cytochrome P450 enzyme 14α-demethylase inhibitor
      insoluble in H2O; ≥10.9 mg/mL
  5. Creatinine
    B1717 Creatinine
    Summary: Break-down product of creatine phosphate in muscle
      insoluble in EtOH; ≥11.3 mg/mL
  6. Levobetaxolol HCl
    B1778 Levobetaxolol HCl
    Summary: Adrenergic receptor antagonist
      ≥17.15 mg/mL
  7. D-Cycloserine
    B1721 D-Cycloserine
    Summary: Antibiotic
      insoluble in DMSO; insoluble in EtOH; ≥51 mg/mL
  8. 3'-Hydroxypterostilbene
    A4685 3'-Hydroxypterostilbene
    Summary: A hydroxylated pterostilbene derivative that inhibits PI3K/Akt and MAPK signaling and induces apoptosis and autophagy for colon cancer
      ≥53.2 mg/mL
  9. PD-1-IN-17
    A9026 PD-1-IN-17
      Soluble in DMSO
  10. Menadiol Diacetate
    C6952 Menadiol Diacetate
    Summary: A vitamin K derivative that induces cell cycle S-phase arrest and apoptosis
      ≥48.9 mg/mL

Items 6261-6270 of 13615

Page
per page